WEATHER ALERT
Top vaccine official resigns from FDA, criticizes RFK Jr. for promoting 'misinformation and lies'
Read full article: Top vaccine official resigns from FDA, criticizes RFK Jr. for promoting 'misinformation and lies'The top vaccine official with the Food and Drug Administration has resigned and criticized the nation's top health official for allowing “misinformation and lies” to guide his thinking behind the safety of vaccinations.
Experimental treatment pushed by ALS patients gets day before FDA, but agency unconvinced it works
Read full article: Experimental treatment pushed by ALS patients gets day before FDA, but agency unconvinced it worksThe Food and Drug Administration meets this week to consider a much-debated treatment for Lou Gehrig’s disease.
New blood donation rules allow more gay men to give in US
Read full article: New blood donation rules allow more gay men to give in USNew blood donations rules will allow sexually active gay and bisexual men in monogamous relationships to give in the U.S. The Food and Drug Administration guidelines ease decades-old restrictions on blood donations put in place to protect the blood supply from HIV.
US grapples with whether to modify COVID vaccine for fall
Read full article: US grapples with whether to modify COVID vaccine for fallU.S. health authorities are facing a critical decision: whether to offer new COVID-19 booster shots this fall that are modified to better match the latest changes of the shape-shifting coronavirus.
:strip_exif(true):strip_icc(true):no_upscale(true):quality(65)/cloudfront-us-east-1.images.arcpublishing.com/gmg/GO4LPGBWCZDNJNK7VLHB7DGKLE.jpg)
Pfizer vaccine for kids may not be available until November
Read full article: Pfizer vaccine for kids may not be available until NovemberPfizer has submitted research to the U.S. Food and Drug Administration on the effectiveness of its COVID-19 vaccine in children but the shots may not be available until November.
:strip_exif(true):strip_icc(true):no_upscale(true):quality(65)/cloudfront-us-east-1.images.arcpublishing.com/gmg/Y4PFRMB4SJHADKJH7DCTZ647QE.jpg)
The Latest: Pfizer gives vaccine data from kids 5-11 to FDA
Read full article: The Latest: Pfizer gives vaccine data from kids 5-11 to FDAPfizer has submitted research to the U.S. Food and Drug Administration on the effectiveness of its COVID-19 vaccine in children as it moves closer to seeking approval for expanded use of the shots.
:strip_exif(true):strip_icc(true):no_upscale(true):quality(65)/d1vhqlrjc8h82r.cloudfront.net/04-13-2021/t_e89646f1007e4c689e7aa78e6a66e774_name_image.jpg)
US recommends ‘pause’ for J&J vaccine over clot reports
Read full article: US recommends ‘pause’ for J&J vaccine over clot reportsThe U.S. recommendation to “pause” use of the single-dose Johnson & Johnson COVID-19 vaccine set off a chain reaction worldwide and dealt a setback to the global vaccine campaign.
:strip_exif(true):strip_icc(true):no_upscale(true):quality(65)/cloudfront-us-east-1.images.arcpublishing.com/gmg/F7V3Q5ZY45GZTINWCNXMGRPN5E.jpg)
The Latest: Oklahoma opens second phase of COVID-19 vaccines
Read full article: The Latest: Oklahoma opens second phase of COVID-19 vaccines(AP Photo/Dmitri Lovetsky)MEXICO CITY — Mexico has received its first shipment of Russia’s Sputnik V COVID-19 vaccine. ___WASHINGTON — The White House now says it expects to catch up by mid-week on deliveries of coronavirus vaccine doses that were delayed by severe weather. AdBeginning March 1, anyone aged 55 to 64 will be allowed to get a COVID-19 vaccine. ___OKLAHOMA CITY — Oklahoma opened its second phase of coronavirus vaccinations on Monday, providing inoculations to public school teachers and staff and to adults of any age with illnesses that make them susceptible to the virus. There have been 419,853 coronavirus cases and 4,203 deaths due to COVID-19 in Oklahoma since the pandemic began, the state health department reported.
:strip_exif(true):strip_icc(true):no_upscale(true):quality(65)/d1vhqlrjc8h82r.cloudfront.net/02-05-2021/t_0f32c270283b4abe9d2c714d90da0988_name_image.jpg)
J&J asks US regulators to OK its one-shot COVID-19 vaccine
Read full article: J&J asks US regulators to OK its one-shot COVID-19 vaccineJohnson & Johnson asked U.S. regulators Thursday to clear the world’s first single-dose COVID-19 vaccine, an easier-to-use option that could boost scarce supplies. J&J’s vaccine was safe and offered strong protection against moderate to severe COVID-19, according to preliminary results from a massive international study. AdDr. Peter Marks, FDA’s vaccine chief, has cautioned against making comparisons before the evidence is all in. OTHER OPTIONSIn large U.S. studies, two doses of the Pfizer and Moderna vaccines proved 95% protective against any symptomatic COVID-19. J&J also is studying a two-dose version of its vaccine, but results won’t be available for several more months.
:strip_exif(true):strip_icc(true):no_upscale(true):quality(65)/cloudfront-us-east-1.images.arcpublishing.com/gmg/FVS3OWLCWZDG5MJTLLWNGQ6XGQ.jpg)
FDA publishes vaccine guidelines opposed by White House
Read full article: FDA publishes vaccine guidelines opposed by White HouseIn the new guidelines posted on its website, the FDA said vaccine makers should follow trial participants for at least two months to rule out any major side effects before seeking emergency approval. That standard had been a sticking point between the FDA and White House officials, who said it could unreasonably delay the availability of COVID-19 vaccines. On Monday Trump said vaccines are coming “momentarily,” in a video recorded after he returned to the White House. The White House attempt to block the guidance followed a string of instances in which the Trump administration has undercut its own medical experts working to combat the pandemic. Beyond exposing the rift between the White House and FDA, the delay in releasing the guidelines may have had limited practical effect.